Recombinant proteins market Latest News

Driven by their target oriented nature that enables them to attack only the diseased cells without affecting the healthy ones, biopharmaceuticals today represent one of the fastest growing segments of the pharmaceutical industry.

The global sales of biologics is expected to grow at 8.2 percent compared to 2011, exceeding values worth US$ 117 billion by the end of 2012.